Keyphrases
Irinotecan
100%
Metastatic Breast Cancer
100%
Topoisomerase
100%
Topotecan
75%
Topoisomerase Inhibitors
25%
Taxanes
25%
Biological Agents
25%
Monotherapy
25%
Anthracyclines
25%
Response Rate
12%
Toxicity Profile
12%
Adverse Events
12%
Clinical Trials
12%
Previously Treated
12%
Neutropenia
12%
Dosing Schedule
12%
Hematologic
12%
Phase II Trial
12%
Diarrhea
12%
Combination Therapy
12%
Nausea-vomiting
12%
Pharmacology, Toxicology and Pharmaceutical Science
DNA Topoisomerase
100%
Metastatic Breast Cancer
100%
Irinotecan
100%
Topotecan
75%
Taxane
25%
Biological Product
25%
Anthracycline
25%
Monotherapy
25%
Nausea and Vomiting
12%
Diseases
12%
Diarrhea
12%
Neutropenia
12%
Combination Therapy
12%
Adverse Event
12%
Clinical Trial
12%
Biological Marker
12%